← Kerr University  |  Daily News
Health & Lifestyle · 9 Proficient · November 20, 2026

New pancreatic cancer drug shows early promise in trials

New pancreatic cancer drug shows early promise in trials
Photo: Wikimedia Commons via Wikimedia Commons

Vocabulary

Article

Researchers have reported encouraging early results from trials of a daily pill called daraxonrasib, which targets a specific genetic mutation found in most pancreatic cancers. In a trial of 61 patients with advanced disease that had spread beyond the pancreas, tumours stopped growing in almost all participants when the drug was combined with chemotherapy. For one in 12 patients, cancer became undetectable on scans. These results represent a significant shift in treating a notoriously difficult cancer, though doctors emphasize the drug is not a cure and longer studies are needed to determine how long the benefit might last.

Kerr University™ subscribers

Get full access to every level and category, plus one-on-one guidance in class

This lesson continues with the full article, natural-voice audio and discussion questions. Subscribers get every Daily News lesson, at every level.

New here? Book a free 30-minute class or try a free sample story.

Open the full interactive lesson with tap-to-hear on every word →

Ready to speak English with real confidence?
Work 1-on-1 with Digby R. Kerr.
Claim Your Free 30-Min Class